Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites

Cancer Letters

Volumn 251, Issue 2, 2007, Pages 220-227

  Li, Shaoyi ^a,b   Gao, Yun ^a   Tokuyama, Tsutomu ^a   Yamamoto, Junkoh ^a   Yokota, Naoki ^a   Yamamoto, Seiji ^a   Terakawa, Susumu ^a   Kitagawa, Masatoshi ^a   Namba, Hiroki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bystander effect; Ganciclovir; Glioma; Herpes simplex virus thymidine kinase; Migration; Neural stem cell

Indexed keywords

GANCICLOVIR; HERPESVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; BRAIN TUMOR; CELL GROWTH; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; GENETIC ENGINEERING; GLIOMA CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; BRAIN NEOPLASMS; BYSTANDER EFFECT; GANCICLOVIR; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIOMA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SIMPLEXVIRUS; STEM CELLS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

RATTUS; SIMPLEXVIRUS;

EID: 34247592355     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.11.024     Document Type: Article

References (23)

1. Surawicz T.S., McCarthy B.J., Kupelian V., Jukich P.J., Bruner J.M., and Davis F.G. Brain tumor survival: results from the National Cancer Data Base. J. Neurooncol. 40 (1998) 151-160
2. DeAngelis L.M. Brain tumors. N. Engl. J. Med. 344 (2001) 114-123
3. Aghi M., Hochberg F., and Breakefield X.O. Prodrug activation enzymes in cancer gene therapy. J. Gene Med. 2 (2000) 148-164
4. Culver K.W., Ram Z., Wallbridge S., Ishii H., Oldfield E.H., and Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256 (1992) 1550-1552
5. Dilber M.S., Abedi M.R., Christensson B., Bjorkstrand B., Kidder G.M., Naus C.C., Gahrton G., and Smith C.I. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res. 57 (1997) 1523-1528
6. Ram Z., Culver K.W., Oshiro E.M., Viola J.J., DeVroom H.L., Otto E., Long Z., Chiang Y., McGarrity G.J., Muul L.M., Katz D., Blaese R.M., and Oldfield E.H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 3 (1997) 1354-1361
7. Rainov N.G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. 11 (2000) 2389-2401
8. Vrionis F.D., Wu J.K., Qi P., Cano W., and Cherington V. A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simplex virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro. J. Neurosurg. 83 (1995) 698-704
9. Tamura M., Shimizu K., Yamada M., Miyao Y., Hayakawa T., and Ikenaka K. Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells. Hum. Gene Ther. 8 (1997) 381-391
10. Namba H., Tagawa M., Iwadate Y., Kimura M., Sueyoshi K., and Sakiyama S. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum. Gene Ther. 9 (1998) 5-11
11. Namba H., Tagawa M., Miyagawa T., Iwadate Y., and Sakiyama S. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir. Cancer Gene Ther. 7 (2000) 947-953
12. Aboody K.S., Brown A., Rainov N.G., Bower K.A., Liu S., Yang W., Small J.E., Herrlinger U., Ourednik V., Breakefield X.O., and Snyder E.Y. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. U.S.A 97 (2000) 12846-12851
13. Ehtesham M., Yuan X., Kabos P., Chung N.H., Liu G., Akasaki Y., Black K.L., and Yu J.S. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 6 (2004) 287-293
14. Zhang Z., Jiang Q., Jiang F., Ding G., Zhang R., Wang L., Zhang L., Robin A.M., Katakowski M., and Chopp M. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 23 (2004) 281-287
15. Shah K., Bureau E., Kim D.E., Yang K., Tang Y., Weissleder R., and Breakefield X.O. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann. Neurol. 57 (2005) 34-41
16. Li S., Tokuyama T., Yamamoto J., Koide M., Yokota N., and Namba H. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther. 12 (2005) 600-607
17. Li S., Tokuyama T., Yamamoto J., Koide M., Yokota N., and Namba H. Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene. Oncology 69 (2005) 503-508
18. Mohanam S., Sawaya R., McCutcheon I., Ali-Osman F., Boyd D., and Rao J.S. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 53 (1993) 4143-4147
19. Temple S. The development of neural stem cells. Nature 414 (2001) 112-117
20. Wennersten A., Meier X., Holmin S., Wahlberg L., and Mathiesen T. Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injury. J. Neurosurg. 100 (2004) 88-96
21. Benedetti S., Pirola B., Pollo B., Magrassi L., Bruzzone M.G., Rigamonti D., Galli R., Selleri S., Di Meco F., De Fraja C., Vescovi A., Cattaneo E., and Finocchiaro G. Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6 (2000) 447-450
22. Barresi V., Belluardo N., Sipione S., Mudo G., Cattaneo E., and Condorelli D.F. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther. 10 (2003) 396-402
23. Ehtesham M., Kabos P., Kabosova A., Neuman T., Black K.L., and Yu J.S. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res. 62 (2002) 5657-5663